Lisata Therapeutics, Inc.
LSTA
$2.28
$0.00010.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.38% | -2.47% | 6.49% | 2.26% | 6.61% |
| Total Depreciation and Amortization | 2.33% | 4.88% | -2.38% | -6.67% | -2.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.21% | -12.05% | 109.02% | 155.77% | -74.13% |
| Change in Net Operating Assets | 136.36% | -134.95% | -124.48% | 642.27% | 81.29% |
| Cash from Operations | 26.77% | -19.30% | -79.83% | 52.34% | 24.82% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.66% | 580.99% | 122.03% | -153.83% | 81.99% |
| Cash from Investing | -94.65% | 578.98% | 122.03% | -153.83% | 81.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.36% | 511.11% | -- | -100.00% | -- |
| Repurchase of Common Stock | 95.88% | -84.09% | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 378.26% | 76.04% | -- | -100.00% | 122.54% |
| Foreign Exchange rate Adjustments | 150.00% | 103.08% | -266.67% | 50.00% | 147.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.38% | 221.45% | 62.43% | -235.39% | 923.35% |